Back
Unilever Plc Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Buy
53
UL
Unilever Plc
Last Price:
$65.47
Seasonality Move:
3.48%
Sell
38
RAPT
Rapt Therapeutics, Inc.
Last Price:
$33.49
Seasonality Move:
-28.15%
Buy
53
Unilever Plc (UL)
is a Buy
Is Unilever Plc a Buy, Sell or Hold?
-
The current Unilever Plc [UL] share price is $65.62. The Score for UL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
UL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.38. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UL Stock Price Chart
What is Unilever Plc's stock price today?
-
The Unilever Plc share price today is $65.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UL is experiencing slight selling pressure.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.38The current trend is moderately bullish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.
UL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 18.27 | Buy |
| Relative Strength Index (14 RSI): | 55.27 | Buy |
| Chaikin Money Flow: | -42984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.72 - 65.58) | Buy |
| Bollinger Bands (100): | (63.81 - 67.01) | Buy |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.71 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | -220916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.11 - 35.93) | Sell |
| Bollinger Bands (100): | (16.49 - 33.77) | Buy |
UL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.57 | Buy |
| 20-day SMA: | 64.69 | Buy |
| 50-day SMA: | 64.97 | Buy |
| 200-day SMA: | 65.62 | Sell |
| 8-day EMA: | 58.85 | Buy |
| 20-day EMA: | 38.96 | Buy |
| 50-day EMA: | 19.83 | Buy |
| 200-day EMA: | 5.64 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.03 | Sell |
| 20-day SMA: | 34.65 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 31.26 | Buy |
| 20-day EMA: | 20.72 | Buy |
| 50-day EMA: | 10.54 | Buy |
| 200-day EMA: | 3 | Buy |
Unilever Plc Earnings Growth & UL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.43 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
Unilever Plc Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||